Acutus Medical Announces Earnings Call Time Change; Fourth Quarter 2020 Earnings Call to Occur at 8 a.m. (Eastern Time)
March 17 2021 - 10:58PM
Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia
management company focused on improving the way cardiac arrhythmias
are diagnosed and treated, announced that it has changed the timing
of its previously announced earnings conference call. The time
change is entirely the result of an error by the Company’s filing
agent, Donnelley Financial Solutions, whereby Donnelley Financial
Solutions inadvertently filed Acutus’ financial results for
automated distribution at 3 a.m. Pacific Time / 6 a.m. Eastern Time
on Thursday, March 18. As a result, Acutus will now host a
conference call to discuss results for the fourth quarter of 2020
on Thursday, March 18 at 5 a.m. Pacific Time / 8 a.m. Eastern Time.
Webcast and Conference Call InformationAcutus
Medical will host a conference call to discuss the fourth quarter
and full year 2020 financial results before market open on
Thursday, March 18, 2021 at 5:00 a.m. Pacific Time / 8:00 a.m.
Eastern Time. The conference call can be accessed live over the
phone (833) 570-1131 for U.S. callers or (914) 987-7078 for
international callers, using conference ID: 1667255. The live
webinar can be accessed at https://ir.acutusmedical.com.
About Acutus Medical, Inc. Acutus Medical is an
arrhythmia management company focused on improving the way cardiac
arrhythmias are diagnosed and treated. Acutus is committed to
advancing the field of electrophysiology with a unique array of
products and technologies which will enable more physicians to
treat more patients more efficiently and effectively. Through
internal product development, acquisitions and global partnerships,
Acutus has established a global sales presence delivering a broad
portfolio of highly differentiated electrophysiology products that
provide its customers with a complete solution for catheter-based
treatment of cardiac arrhythmias. Founded in 2011, Acutus is based
in Carlsbad, California.
Caution Regarding Forward-Looking
StatementsThis press release includes statements that may
constitute “forward-looking” statements, usually containing the
words “believe,” “estimate,” “project,” “expect” or similar
expressions. Forward-looking statements inherently involve risks
and uncertainties that could cause actual results to differ
materially from the forward-looking statements. Factors that would
cause or contribute to such differences include, but are not
limited to, the Company's ability to continue to manage expenses
and cash burn rate at sustainable levels, continued acceptance of
the Company's products in the marketplace, the effect of global
economic conditions on the ability and willingness of customers to
purchase its systems and the timing of such purchases, competitive
factors, changes resulting from healthcare policy in the United
States, including changes in government reimbursement of
procedures, dependence upon third-party vendors and distributors,
timing of regulatory approvals, the impact of the coronavirus
(COVID-19) pandemic and our response to it, and other risks
discussed in the Company's periodic and other filings with the
Securities and Exchange Commission. By making these forward-looking
statements, the Company undertakes no obligation to update these
statements for revisions or changes after the date of this release,
except as required by law.
Investor Contact:Caroline CornerWestwicke ICRD:
415-314-1725Caroline.corner@westwicke.com
Holly WindlerM: 619-929-1275media@acutusmedical.com
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Aug 2024 to Sep 2024
Acutus Medical (NASDAQ:AFIB)
Historical Stock Chart
From Sep 2023 to Sep 2024